TCL Archive NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says. November 23, 2007
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program November 1, 1985
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000